{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/alopecia-areata/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"60aecd9c-54ab-5403-9a4b-560ca30c2cab","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 2cb6e4e8-07b0-4405-a389-ad0f039a3202 --><h2>Changes</h2><!-- end field 2cb6e4e8-07b0-4405-a389-ad0f039a3202 -->","summary":null,"htmlStringContent":"<!-- begin item 5253421c-3067-4635-ae17-d36c46de9a61 --><!-- begin field 90abe376-2d44-4fcd-8a2f-d271d00db032 --><p><strong>March 2018</strong> — reviewed. A literature search was conducted in February 2018 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of this topic. The topic has undergone minor restructuring. A Complications node has been added to the Background information section. The management recommendations have been updated in line with the current literature. The Prescribing Information section has been deleted and links made to relevant CKS topics.</p><!-- end field 90abe376-2d44-4fcd-8a2f-d271d00db032 --><!-- end item 5253421c-3067-4635-ae17-d36c46de9a61 -->","topic":{"id":"3f506159-b4f8-5d05-890d-a64054e84ccb","topicId":"2d81e675-d977-447f-ada9-76e40512ec53","topicName":"Alopecia areata","slug":"alopecia-areata","lastRevised":"Last revised in March 2018","chapters":[{"id":"6e5fa7b5-85f4-59b0-b6d5-af565dbeca62","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"1ef94739-401e-5240-a534-26d735579c9b","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"c1849e2f-7e6d-5cb1-b414-04f57f0b44e8","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"60aecd9c-54ab-5403-9a4b-560ca30c2cab","slug":"changes","fullItemName":"Changes"},{"id":"992927df-46f8-54cd-91ba-ab482b795e2a","slug":"update","fullItemName":"Update"}]},{"id":"b6d1675d-a7b4-56f6-8b4b-d1e7fe509d84","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"0d91cb19-fc33-5794-9d8a-d34b80eb0ca7","slug":"goals","fullItemName":"Goals"},{"id":"95f55e76-dc6a-5839-a9bc-6d08dff8a48c","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6952b518-4f15-54a9-8921-3e86dab6294e","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"37f78a6d-d8e6-58dc-88c9-4d3e05abecca","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"5786cc77-35e5-56a7-a992-49572f1ddbff","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ff8a9027-8325-5120-bb54-b9558acbf8d3","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"70bde073-0253-57b5-94cd-11aa4b58ad0c","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"78760e5a-2799-521d-844a-07bc440242d4","slug":"definition","fullItemName":"Definition"},{"id":"2888a070-fe4a-561d-995d-52108dceef1a","slug":"causes","fullItemName":"Causes"},{"id":"bc27a336-3e29-5193-ad4c-18b4ac8feadd","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0111ec0d-2dd3-5f43-84a0-cf302a16ec36","slug":"complications","fullItemName":"Complications"},{"id":"94d11477-56d1-53b6-9c80-7595b2511b5a","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"2ea290a5-5410-5910-b84e-abb8476bfc60","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"f9c98bbb-23f2-5b32-b892-5f8709852055","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"4ae05ff0-b665-5913-a01f-e4896578c002","slug":"assessment","fullItemName":"Assessment"},{"id":"54d1dc12-5454-568e-ac30-1f25505e5c62","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"7a80c310-0d6e-5245-a1d1-50caabe2c06d","fullItemName":"Management","slug":"management","subChapters":[{"id":"300e3368-9d07-5c14-adbe-f7b64bc4c491","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"e66233f3-5c43-5dfe-a429-61e0647ed247","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"79cb08ba-64b8-5d29-9752-5524da0e07aa","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"7ef577cd-1465-58aa-857b-7233384f3c79","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f74600a9-541c-5350-80d3-5b5eee4ce68f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"574414e0-6fed-5a13-bceb-9656dbd03404","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"1511ad3d-a756-5d29-8579-437ed5a4e047","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"df66156c-b1ba-53cf-9d34-8432f7155653","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"85a1886f-4119-5f2c-a3cb-28edc69384f0","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"c1849e2f-7e6d-5cb1-b414-04f57f0b44e8","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"9d4156e4-74df-57e7-bcac-ba268f4974b1","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 49f73566-ed81-463f-b611-a7800109acc6 --><h3>Previous changes</h3><!-- end field 49f73566-ed81-463f-b611-a7800109acc6 -->","summary":null,"htmlStringContent":"<!-- begin item b6eff6a1-4ab7-46a0-88c7-a7800109aa6a --><!-- begin field e141f662-ce86-4967-9e38-a7800109acc6 --><p><strong>May 2014 </strong>— minor update. A link to prescriptions has been removed from the management text and some text added to give examples of potent and very potent topical corticosteroids.</p><p><strong>June 2013 </strong>— reviewed. A literature search was conducted in June 2013 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. No major changes to clinical recommendations have been made.</p><p><strong>February to June 2009 </strong>— converted from CKS guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence. Minoxidil is no longer offered as a primary care treatment option.</p><p><strong>October to December 2005</strong> — written. Validated in March 2006 and issued in May 2006.</p><!-- end field e141f662-ce86-4967-9e38-a7800109acc6 --><!-- end item b6eff6a1-4ab7-46a0-88c7-a7800109aa6a -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}